Market Tracker

05/27 5:16pm ET

BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

3.38
Delayed Data
As of May 27
 +0.02 / +0.60%
Today’s Change
1.63
Today|||52-Week Range
16.83
-67.25%
Year-to-Date
No recent news for BioCryst Pharmaceuticals Inc.

Today’s Trading

Previous close3.36
Today’s open3.36
Day’s range3.23 - 3.39
Volume834,907
Average volume (3 months)1,382,120
Market cap$249.1M
Dividend yield--
Data as of 3:59pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)+13.24%
Earnings growth (this year)-76.46%
Earnings growth (next 5 years)+24.73%
Revenue growth (last year)+254.62%
P/E ratioNM
Price/Sales15.59
Price/Book5.20

Competitors

 Today’s
change
Today’s
% change
BPTHBio Path Holdings In...+0.04+1.48%
ONVOOrganovo Holdings In...+0.10+3.69%
OVASOvaScience Inc-0.03-0.43%
EDGEEdge Therapeutics In...+0.05+0.63%
Data as of 4:01pm ET, 05/27/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$48.3M
Annual profit (last year)-$43.0M
Net profit margin-89.15%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jon P. Stonehouse
Vice President-Investor Relations &
Operations
Robert Bennett
Corporate headquarters
Durham, North Carolina

Forecasts